Total Funding
39
2
Total FundingVenture - Series Unknown raised
Growth Score 39 in past quarter
-2 pts
Heat Score 2 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
580150
Kalyra Pharmaceuticals is a small molecule drug discovery and development company focused on creating best-in-class medicines.
Cam Gallagher: Chief Business OfficerPast Role: Zavante Therapeutics, Co-Founder & Chief Business Officer- Kevin Bunker: Co-Founder, CSOPast Role: Zentalis Pharmaceuticals, Chief Operating Officer
About the Company
Kalyra Pharmaceuticals is a small molecule drug discovery and development company focused on creating best-in-class medicines. The company develops next-generation drugs. It also offers customized optimization services for companies advancing drug leads toward the clinic. The company was founded in 2012 and is based in Escondido, California.
